The Untapped Power of Resistance Exercise in Managing Diabetes and Enhancing Health and Wellness

Abstract

Get full access to this article

View all access options for this article.

References

American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription. Lippincott Williams & Wilkins; 2022.

American Diabetes Association Professional Practice Committee. 5. Facilitating positive health behaviors and well-being to improve health outcomes: Standards of Care in Diabetes — 2024. Diabetes Care. 2024;47(suppl 1):S77-S110. doi:10.2337/dc24-S005

Centers for Disease Control and Prevention/National Center for Health Statistics. Physical activity among adults aged 18 and over: United States, 2020. Accessed April 3, 2024. https://www.cdc.gov/nchs/products/databriefs/db443.htm

Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association. Med Sci Sports Exer. 2010;42(12):2282-2303.

Foster

Florhaug

Franklin

, et al. A new approach to monitoring exercise training. J Strength Cond Res. 2001;15(1):109-115.

Hurley

Flippin

Blom

, et al. Practices, perceived benefits, and barriers to resistance training among women enrolled in college. Int J Exerc Sci. 2018;1 1(5):226-238.

Hurst

Dismore

Granic

, et al. Attitudes and barriers to resistance exercise training for older adults living with multiple long-term conditions, frailty, and a recent deterioration in health: qualitative findings from the Lifestyle in Later Life - Older People’s Medicine (LiLL-OPM) study. BMC Geriatr. 2023;23(1):772. doi:10.1186/s12877-023-04461-5

Kanaley

Colberg

Corcoran

, et al. Exercise/physical activity in individuals with type 2 diabetes: a consensus statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2022;54(2):353-368.

McLean

Kiel

DP.

Developing consensus criteria for sarcope-nia: an update. J Bone Miner Res. 2015;30(4):588-592.

10.

Rivera

Fonseca-Sanchez

Rodriguez

, et al. Physical activity protects men but not women for sarcopenia development. Gerontol Geriatr Med. 2016;2:2333721416667879. doi:10.1177/2333721416667879

11.

Yuan

Larsson

SC.

Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism. 2023;144:155533. doi:10.1016/j.metabol.2023.155533